Table 4.
Homes with 3 weeks of data |
Homes with at least 2 weeks of data |
Homes with 3 weeks of data |
Homes with at least 2 weeks of data |
|||||
---|---|---|---|---|---|---|---|---|
ICC | m | ICC | m | ICC | m | ICC | m | |
trans-permethrin | 0.75 | 1.4 | 0.71 | 1.7 | 0.77 | 1.2 | 0.73 | 1.5 |
cis-permethrin | 0.74 | 1.4 | 0.74 | 1.4 | 0.76 | 1.3 | 0.7 | 1.7 |
Cypermethrin | 0.72 | 1.6 | 0.71 | 1.7 | 0.94 | 0.3 | 0.92 | 0.3 |
Esfenvalerate | 0.71 | 1.6 | 0.8 | 1 | 0.87 | 0.6 | 0.86 | 0.6 |
Deltamethrin | 0.82 | 0.9 | 0.74 | 1.4 | 0.92 | 0.4 | 0.89 | 0.5 |
Bifenthrin | 0.75 | 1.4 | 0.55 | 3.3 | 0.95 | 0.2 | 0.94 | 0.3 |
Cyfluthrin | 0.84 | 0.8 | 0.78 | 1.2 | 0.96 | 0.2 | 0.88 | 0.5 |
Cyhalothrin | 0.91 | 0.4 | 0.67 | 2 | 0.91 | 0.4 | 0.86 | 0.6 |
All pyrethroids | 0.82 | 0.9 | 0.74 | 1.4 | 0.82 | 0.9 | 0.77 | 1.2 |
n = 50 houses when 2 and 3 sample collection weeks are included. Thirty-nine houses when data for houses having only 3 sample collection weeks, n for non-substituted data is further reduced according to frequency of detection (Table 2).